Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Summit Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Summit Therapeutics Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Summit Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Summit Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Summit Therapeutics Plc, Medical Devices Deals, 2011 to YTD 2017 10
Summit Therapeutics Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Summit Therapeutics Plc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Summit (Oxford) Enters into Contract with Biomedical Advanced Research and Development Authority 12
Summit Therapeutics Enters into Agreement with University of Oxford 13
Licensing Agreements 14
Sarepta Therapeutics Enters into Licensing Agreement with Summit Therapeutics 14
Summit Enters Into Licensing Agreement With Bristol-Myers Squibb For Seglin Technology 15
Equity Offering 16
Summit Therapeutics Raises USD20.1 Million in Public Offering of Shares 16
Summit Therapeutics Raises Funds in Private Placement of Shares upon Exercise of Warrants 18
Summit Therapeutics Raises USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 19
Summit Therapeutics Completes Initial Public Offering of American Depositary Shares 20
Summit Completes Private Placement Of Shares For US$34.4 Million 22
Summit Completes Private Placement Of Shares For US$1.6 Million 23
Summit Completes Private Placement Of Shares For US$7 Million 24
Summit Completes Private Placement Of Shares For US$0.1 Million 25
Summit Announces Private Placement Of Shares For US$8 Million 26
Summit Completes Private Placement Of Common Stock For US$2.2 Million 27
Acquisition 28
Summit Acquires MuOx for USD5.3 Million 28
Summit Therapeutics Plc – Key Competitors 29
Summit Therapeutics Plc – Key Employees 30
Summit Therapeutics Plc – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Financial Announcements 32
Aug 31, 2017: Summit Therapeutics Reports Financial Results For The Second Quarter And Half Year Ended 31 July 2017 And Operational Progress 32
Jun 14, 2017: Summit Therapeutics Reports Financial Results For The First Quarter Ended 30 April 2017 And Operational Progress 35
Mar 29, 2017: Summit Therapeutics Reports 4th Quarter and Year End Financial Results and Operational Progress 37
Dec 15, 2016: Summit Therapeutics Reports Financial Results for the Third Quarter Ended 31 October 2016 and Operational Progress 38
Sep 08, 2016: Summit Therapeutics Reports Financial Results For The Second Quarter Ended 31 July 2016 And Operational Progress 39
Jun 02, 2016: Summit Therapeutics Reports Financial Results for the First Quarter Ended 30 April 2016 and Operational Progress 40
May 10, 2016: Summit Therapeutics Reports Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2016 41
Corporate Communications 42
May 23, 2017: Summit Announces Key Appointments to Strengthen Research & Development Team 42
Jan 18, 2017: Summit Appoints Dr David Roblin as Chief Operating Officer and President of Research & Development 44
Product News 45
03/15/2016: Summit Announces Publication on Biomarkers to Quantify Utrophin Protein and Regeneration of Muscle Fibres in DMD 45
Clinical Trials 46
Jan 21, 2016: Summit Therapeutics Receives Regulatory Approval to Initiate PhaseOut DMD, a Phase 2 Clinical Trial of SMT C1100 in Patients With DMD 46
Other Significant Developments 47
Mar 30, 2017: Summit Therapeutics: Change of Registered Office 47
Mar 30, 2017: Summit Announces Change Of Registered Company Address 48
Sep 12, 2016: Summit Launches Online Resource on Utrophin Modulation for the Duchenne Muscular Dystrophy Community 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50
Summit Therapeutics Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Summit Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Summit Therapeutics Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Summit Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Summit Therapeutics Plc, Deals By Therapy Area, 2011 to YTD 2017 9
Summit Therapeutics Plc, Medical Devices Deals, 2011 to YTD 2017 10
Summit Therapeutics Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Summit (Oxford) Enters into Contract with Biomedical Advanced Research and Development Authority 12
Summit Therapeutics Enters into Agreement with University of Oxford 13
Sarepta Therapeutics Enters into Licensing Agreement with Summit Therapeutics 14
Summit Enters Into Licensing Agreement With Bristol-Myers Squibb For Seglin Technology 15
Summit Therapeutics Raises USD20.1 Million in Public Offering of Shares 16
Summit Therapeutics Raises Funds in Private Placement of Shares upon Exercise of Warrants 18
Summit Therapeutics Raises USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 19
Summit Therapeutics Completes Initial Public Offering of American Depositary Shares 20
Summit Completes Private Placement Of Shares For US$34.4 Million 22
Summit Completes Private Placement Of Shares For US$1.6 Million 23
Summit Completes Private Placement Of Shares For US$7 Million 24
Summit Completes Private Placement Of Shares For US$0.1 Million 25
Summit Announces Private Placement Of Shares For US$8 Million 26
Summit Completes Private Placement Of Common Stock For US$2.2 Million 27
Summit Acquires MuOx for USD5.3 Million 28
Summit Therapeutics Plc, Key Competitors 29
Summit Therapeutics Plc, Key Employees 30
Summit Therapeutics Plc, Subsidiaries 31